drugset / Trial / NCT01768299

Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)

NCT01768299

Phase 4 Completed 504 enrolled Gynuity Health Projects
RandomizedParallel-groupDouble-blindTreatment

Summary

A double-blind randomized controlled trial to compare a shorter interval between the administration of mifepristone and misoprostol (simultaneous administration compared to 24hours from administration of mifepristone to receipt of the first dose of misoprostol) for termination of pregnancy up to 13-22 weeks of gestation. The investigators hypothesize that a shortened interval may achieve comparable efficacy in terminating pregnancy, whilst reducing the duration of the procedure and in turn, the duration of hospitalization.

Timeline

Start
2013-02
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 200 mg Oral
Background Misoprostol Other / unclassified 400 ug Other

Indications

No indication recorded.